Citation Impact
Citing Papers
Risk Factors for Venous Thromboembolism
2003 Standout
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Parenteral Anticoagulants
2012 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
2010
Hyperhomocysteinaemia
1999
Mechanisms of Thrombus Formation
2008 Standout
Triggers, targets and treatments for thrombosis
2008 Nature
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
2003
Molecular Bases for Circadian Clocks
1999 Standout
Platelet functions and clinical effects in acute myelogenous leukemia
2007
Anti‐protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation
2005
Contribution of platelets to tumour metastasis
2011 Standout
Venous thromboembolism: disease burden, outcomes and risk factors
2005
Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles
2009
Evidence of platelet activation in multiple sclerosis
2008
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
2016
Pancreatic cancer
2020 Standout
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
1994
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Apixaban for Extended Treatment of Venous Thromboembolism
2012
5 Thrombophilia: The Discovery of Activated Protein C Resistance
1995
Perioperative Management of Antithrombotic Therapy
2012 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Platelet activation and reactivity in the convalescent phase of ischaemic stroke
2010
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
2001
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
2006
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
2008
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting
2006
Guidelines for the Primary Prevention of Stroke
2010
The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation
1999
Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events
2005
Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients
2005
Ambient particulate matter accelerates coagulation via an IL-6–dependent pathway
2007
Pulmonary embolism and deep vein thrombosis
2012
High D ‐dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes
2006
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Deep Venous Thrombosis
2004
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients
2008
Membrane microvesicles: Macromessengers in cancer disease and progression
2010
Microparticles in Cancer
2010
Chronic Idiopathic Thrombocytopenic Purpura
1994
Oral Contraceptives and the Risk of Venous Thrombosis
2001
Microparticles, thrombosis and cancer
2009
Immune Thrombocytopenic Purpura
2002 Standout
The Antiphospholipid Syndrome
2002 Standout
Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers
2006
The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*
2004 Standout
Pre-analytical and analytical issues in the analysis of blood microparticles
2010
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Emerging Biological Principles of Metastasis
2017 Standout
The Perioperative Management of Antithrombotic Therapy
2008
D‐dimer at venous thrombosis diagnosis is associated with risk of recurrence
2017
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Pre-eclampsia, the Placenta and the Maternal Systemic Inflammatory Response—A Review
2003
Disseminated Intravascular Coagulation
1999 Standout
Current approaches and controversial issues in the diagnosis of deep vein thrombosis via duplex Doppler ultrasound
2006
Deep Venous Thrombosis After Knee Arthroscopy: A Meta-analysis
2005
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?
2008
Should Patients with Venous Thromboembolism Be Screened for Thrombophilia?
2008
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Frailty in elderly people
2013 Standout
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Prothrombin 20210A Mutation
2004
Nutritional interventions for preventing and treating pressure ulcers
2014
Latest Advances in Understanding Preeclampsia
2005 StandoutScience
Extracellular DNA traps promote thrombosis
2010 Standout
The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis
2007
Venous thromboembolism in travellers: can we identify those at risk?
2003
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Inherited thrombophilia: pathogenesis, clinical syndromes, and management [see comments]
1996
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System
2003
Heme Oxygenases in Cardiovascular Health and Disease
2016
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo
2009
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Inherited Thrombophilia: Part 1
1996
Guidelines for the Primary Prevention of Stroke
2014 Standout
Natural History of Venous Thromboembolism
2003
A Pilot Study to Assess the Feasibility of a Multicenter Cluster Randomized Trial for the Management of Asymptomatic Persons with a Thrombophilia
2009
Factor V Leiden Mutation Is a Risk Factor for Cerebral Venous Thrombosis
1998
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
2014
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
The Pathogenesis of Venous Thromboembolism: Evidence for Multiple Interrelated Causes
2006
The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management
2006
The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus
1999
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene
1996 StandoutScience
Heparin Blunts Endotoxin-Induced Coagulation Activation
1999
Venous thrombosis: a multicausal disease
1999 Standout
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
2002
Serum HIV-1 RNA Levels and Time to Development of AIDS in the Multicenter Hemophilia Cohort Study
1996
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
2014
The Epidemiology of Venous Thromboembolism in the Community
2001
Platelet-derived microparticles and coagulation activation in breast cancer patients
2008
Works of Sabine Eichinger being referenced
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
2006
6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII
2008
Aspirin for Preventing the Recurrence of Venous Thromboembolism
2012
The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor V Leiden and a First Spontaneous Venous Thromboembolism
2002
Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence
2008
Overweight, Obesity, and the Risk of Recurrent Venous Thromboembolism
2008
Superficial thrombophlebitis and risk for recurrent venous thromboembolism
2003
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
2000
No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene
1999
Risk assessment for recurrent venous thrombosis
2010
Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V
1994
Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism
2008
The risk of recurrent venous thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism
2003
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
2012
Symptomatic Pulmonary Embolism and the Risk of Recurrent Venous Thromboembolism
2004
Clinical significance of lupus anticoagulants in children
1999
D-Dimer Levels and Risk of Recurrent Venous Thromboembolism
2003
Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate
1994
The risk of recurrent venous thromboembolism among patients with high factor IX levels
2003
Energy Metabolism in Patients With Acute and Chronic Liver Disease
1990
The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease
2005
The Risk of Recurrent Venous Thromboembolism in Men and Women
2004
Deep vein thrombosis
2005
Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation
2006
The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study
2014
Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism
2010
The Association between Tissue Factor-Exposing Microparticles and the Activation of the Coagulation System in Cancer Patients.
2004
The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene
1999
Levels of Prothrombin Fragment F1+2 in Patients with Hyperhomocysteinemia and a History of Venous Thromboembolism
1997
Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication
1994
Inhibition rather than Enhancement of Hemostatic System Activation during Initiation of Oral Anticoagulant Treatment
1997
Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin Gene
1998
The Risk of Thromboembolism in Asymptomatic Patients with Protein C and Protein S Deficiency: A Prospective Cohort Study
1994
Circulating P-selectin and the risk of recurrent venous thromboembolism
2007
Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
1996
Prospective Evaluation of Hemostatic System Activation and Thrombin Potential in Healthy Pregnant Women with and without Factor V Leiden
1999
The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden
1997
Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer
2007
Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value
1993
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of d -Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism
2010
Effects of Recombinant Hirudin (r-Hirudin, HBW 023) on Coagulation and Platelet Activation In Vivo
1995